Total Payments
$743.91
2024 Payments
$100.49
Companies
8
Transactions
34
Medicare Patients
2,425
Medicare Billing
$640,824
Payment Breakdown by Category
Food & Beverage$535.39 (72.0%)
Education$208.52 (28.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $535.39 | 29 | 72.0% |
| Education | $208.52 | 5 | 28.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $239.16 | 3 | $0 (2021) |
| Travere Therapeutics, Inc. | $217.61 | 19 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $84.56 | 4 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $71.95 | 2 | $0 (2019) |
| Keryx Biopharmaceuticals, Inc. | $65.90 | 3 | $0 (2018) |
| Amgen Inc. | $26.74 | 1 | $0 (2020) |
| Aurinia Pharma U.S., Inc. | $19.69 | 1 | $0 (2021) |
| Relypsa, Inc. | $18.30 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100.49 | 9 | Travere Therapeutics, Inc. ($100.49) |
| 2023 | $117.12 | 10 | Travere Therapeutics, Inc. ($117.12) |
| 2021 | $307.12 | 6 | AstraZeneca Pharmaceuticals LP ($239.16) |
| 2020 | $63.03 | 3 | Mallinckrodt Hospital Products Inc. ($36.29) |
| 2019 | $61.20 | 1 | Otsuka America Pharmaceutical, Inc. ($61.20) |
| 2018 | $33.32 | 2 | Keryx Biopharmaceuticals, Inc. ($22.57) |
| 2017 | $61.63 | 3 | Keryx Biopharmaceuticals, Inc. ($43.33) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $5.57 | General |
| 06/13/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $2.67 | General |
| 04/03/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $11.46 | General |
| 02/14/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $7.17 | General |
| 02/13/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.09 | General |
| 02/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/31/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $5.44 | General |
| 01/30/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.93 | General |
| 01/30/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $1.27 | General |
| 11/22/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $9.26 | General |
| 11/22/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $8.55 | General |
| 10/03/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.29 | General |
| 07/26/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $5.88 | General |
| 07/19/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.99 | General |
| 07/19/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $5.98 | General |
| 06/08/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.01 | General |
| 06/08/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $5.07 | General |
| 03/16/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.68 | General |
| 03/16/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $12.41 | General |
| 10/28/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/27/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 04/20/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/24/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/28/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 539 | 1,242 | $305,582 | $154,999 |
| 2022 | 10 | 598 | 1,356 | $305,724 | $154,128 |
| 2021 | 9 | 651 | 1,541 | $366,129 | $191,229 |
| 2020 | 11 | 637 | 1,334 | $282,618 | $140,469 |
Total Patients
2,425
Total Services
5,473
Medicare Billing
$640,824
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 35 | 245 | $129,850 | $64,712 | 49.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 127 | 333 | $53,150 | $30,270 | 57.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 89 | 269 | $29,590 | $16,278 | 55.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 102 | 124 | $24,800 | $12,288 | 49.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 25 | 46 | $20,240 | $10,201 | 50.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 62 | $15,440 | $8,206 | 53.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 85 | $16,150 | $7,527 | 46.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 33 | 66 | $12,342 | $3,621 | 29.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,020 | $1,895 | 47.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 35 | 197 | $104,410 | $53,745 | 51.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 134 | 355 | $56,475 | $28,054 | 49.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 120 | 365 | $40,150 | $20,104 | 50.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 109 | 135 | $27,000 | $14,015 | 51.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 68 | 90 | $20,745 | $11,992 | 57.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 20 | 38 | $16,720 | $8,776 | 52.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 13 | 27 | $11,880 | $6,247 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 56 | $9,590 | $4,864 | 50.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 38 | 82 | $15,334 | $4,617 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $3,420 | $1,713 | 50.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 55 | 293 | $150,394 | $80,729 | 53.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 134 | 350 | $55,285 | $28,164 | 50.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 142 | 426 | $46,860 | $23,742 | 50.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 119 | 149 | $29,800 | $15,664 | 52.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 28 | 50 | $21,100 | $11,163 | 52.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 63 | 84 | $18,060 | $11,148 | 61.7% |
About Dr. Walid Kassir, M.D
Dr. Walid Kassir, M.D is a Nephrology healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710952098.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walid Kassir, M.D has received a total of $743.91 in payments from pharmaceutical and medical device companies, with $100.49 received in 2024. These payments were reported across 34 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($535.39).
As a Medicare-enrolled provider, Kassir has provided services to 2,425 Medicare beneficiaries, totaling 5,473 services with total Medicare billing of $640,824. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Latrobe, PA
- Active Since 02/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1710952098
Products in Payments
- FARXIGA (Drug) $125.37
- LOKELMA (Drug) $113.79
- ACTHAR (Biological) $84.56
- SAMSCA (Drug) $71.95
- Auryxia (Drug) $65.90
- Parsabiv (Drug) $26.74
- LUPKYNIS (Drug) $19.69
- Veltassa (Drug) $18.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.